[Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
Forestier
E
E
Service de maladies infectieuses, centre hospitalier, Chambéry cedex, France. emmanuel.forestier@ch-chambery.fr
Labe
A
A
Raffenot
D
D
Lecomte
C
C
Rogeaux
O
O
D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D053626:Atovaquone / Q000008:administration & dosage / Q000627:therapeutic use*; D002555:Cerebrospinal Fluid / Q000166:cytology; D003072:Cognition Disorders / Q000209:etiology* / Q000503:physiopathology; D003221:Confusion / Q000209:etiology* / Q000503:physiopathology; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D020803:Encephalitis, Herpes Simplex / Q000175:diagnosis; D006505:Hepatitis / Q000209:etiology / Q000469:parasitology; D006801:Humans; D018655:Lymphocyte Count; D016779:Malaria, Cerebral / Q000175:diagnosis; D016778:Malaria, Falciparum / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008582:Meningitis, Aseptic / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000209:etiology; D008875:Middle Aged; D018512:Parasitemia / Q000150:complications / Q000188:drug therapy; D002727:Proguanil / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D013577:Syndrome
D000962:Antimalarials; D002727:Proguanil; D053626:Atovaquone